These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3603673)
41. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831 [TBL] [Abstract][Full Text] [Related]
42. Composite skin graft: frozen dermal allografts support the engraftment and expansion of autologous epidermis. Heck EL; Bergstresser PR; Baxter CR J Trauma; 1985 Feb; 25(2):106-12. PubMed ID: 3882973 [TBL] [Abstract][Full Text] [Related]
43. The role of macrophages and nitric oxide in the effector phase of allotransplantation reaction. Holán V; Krulová M; Pindjaková J; Zajícová A Ann Transplant; 2001; 6(1):44-6. PubMed ID: 11803606 [TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic studies on human epithelial autografts and allografts. Nakano M; Yoshida T; Ohura T; Azami K; Senoo A; Fuse Y Plast Reconstr Surg; 1992 Nov; 90(5):899-909. PubMed ID: 1410042 [TBL] [Abstract][Full Text] [Related]
45. Induction of unresponsiveness to major transplantable organs in adult mammals: a recapitulation of ontogeny by irradiation and bone marrow replacement. Rapaport FT; Bachvaroff RJ; Mollen N; Hirasawa H; Asano T; Ferrebee JW Ann Surg; 1979 Oct; 190(4):461-73. PubMed ID: 384942 [TBL] [Abstract][Full Text] [Related]
46. Graft survival and cytokine production profile after limbal transplantation in the experimental mouse model. Lenčová A; Pokorná K; Zajícová A; Krulová M; Filipec M; Holáň V Transpl Immunol; 2011 Apr; 24(3):189-94. PubMed ID: 21118723 [TBL] [Abstract][Full Text] [Related]
47. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10). Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464 [TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo effects of monoclonal antibodies against T cell subsets on allogeneic and xenogeneic responses in the rat. van den Bogaerde J; White D; Roser B; Kampinga J; Aspinall R Transplantation; 1990 Dec; 50(6):915-20. PubMed ID: 2256161 [TBL] [Abstract][Full Text] [Related]
49. Cellular repopulation of human vein allograft bypass grafts. Johnson TR; Tomaszewski JE; Carpenter JP J Vasc Surg; 2000 May; 31(5):994-1002. PubMed ID: 10805891 [TBL] [Abstract][Full Text] [Related]
50. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773 [TBL] [Abstract][Full Text] [Related]
51. Split tolerance to a composite tissue allograft in a swine model. Mathes DW; Randolph MA; Solari MG; Nazzal JA; Nielsen GP; Arn JS; Sachs DH; Lee WP Transplantation; 2003 Jan; 75(1):25-31. PubMed ID: 12544866 [TBL] [Abstract][Full Text] [Related]
52. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD; Pham S; Li S; Aitouche A Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367 [TBL] [Abstract][Full Text] [Related]
53. Cytokine expression during orthotopic corneal allograft rejection in mice. Sano Y; Osawa H; Sotozono C; Kinoshita S Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419 [TBL] [Abstract][Full Text] [Related]
54. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
55. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [TBL] [Abstract][Full Text] [Related]
56. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts. Djamali A; Odorico JS Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278 [TBL] [Abstract][Full Text] [Related]
57. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells. Nanishi F; Nomoto K; Taniguchi K; Kubo C Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243 [TBL] [Abstract][Full Text] [Related]
58. Importance of natural killer cells in the rejection of hamster skin xenografts. Gourlay WA; Chambers WH; Monaco AP; Maki T Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210 [TBL] [Abstract][Full Text] [Related]
59. Bridging to transplant: allogeneic heart transplantation after xenografting. Hammer C; Schütz A; Pratschke J; Breuer M; Engelhardt M; Brandl U; Saumweber D; Babic R; Kemkes BM; Reichart B J Heart Lung Transplant; 1992; 11(4 Pt 2):S182-8. PubMed ID: 1515437 [TBL] [Abstract][Full Text] [Related]
60. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Li H; Colson YL; Ildstad ST Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]